Northern Trust Corp lessened its holdings in shares of Kewaunee Scientific Co. (NASDAQ:KEQU - Free Report) by 3.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 278,952 shares of the technology company's stock after selling 8,836 shares during the period. Northern Trust Corp owned 9.72% of Kewaunee Scientific worth $17,259,000 as of its most recent filing with the SEC.
Other hedge funds also recently modified their holdings of the company. JPMorgan Chase & Co. raised its position in shares of Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock valued at $30,000 after purchasing an additional 900 shares during the period. IFP Advisors Inc purchased a new stake in shares of Kewaunee Scientific in the 4th quarter valued at $36,000. Morgan Dempsey Capital Management LLC purchased a new stake in shares of Kewaunee Scientific in the 4th quarter valued at $106,000. Barclays PLC purchased a new stake in shares of Kewaunee Scientific in the 3rd quarter valued at $121,000. Finally, Wedbush Securities Inc. purchased a new stake in shares of Kewaunee Scientific in the 4th quarter valued at $262,000. Institutional investors and hedge funds own 32.69% of the company's stock.
Analyst Ratings Changes
Separately, StockNews.com cut shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.
Get Our Latest Stock Report on KEQU
Kewaunee Scientific Stock Up 0.7%
Shares of Kewaunee Scientific stock traded up $0.27 during trading on Tuesday, hitting $37.58. The company's stock had a trading volume of 1,840 shares, compared to its average volume of 24,128. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. The company has a fifty day simple moving average of $37.41 and a two-hundred day simple moving average of $47.69. The company has a market capitalization of $107.29 million, a PE ratio of 5.93 and a beta of 0.47. Kewaunee Scientific Co. has a 52 week low of $30.33 and a 52 week high of $71.33.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. The firm had revenue of $67.17 million during the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.
Insider Activity
In other Kewaunee Scientific news, CFO Donald T. Gardner III sold 3,000 shares of the business's stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of $40.01, for a total transaction of $120,030.00. Following the transaction, the chief financial officer now owns 18,358 shares in the company, valued at $734,503.58. The trade was a 14.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Keith M. Gehl acquired 1,000 shares of the stock in a transaction that occurred on Friday, April 4th. The stock was acquired at an average cost of $35.00 per share, with a total value of $35,000.00. Following the completion of the purchase, the director now owns 18,500 shares of the company's stock, valued at $647,500. This trade represents a 5.71% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold a total of 11,057 shares of company stock worth $440,326 over the last quarter. Insiders own 14.20% of the company's stock.
About Kewaunee Scientific
(
Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Read More

Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.